ABCL Earnings Preview: Options Price a ±18.8% Move
· The NYC Memo · ABCL reports 2026-11-05
AbCellera Biologics Inc. reports November 5, 2026. The November 20, 2026 straddle implies ±18.81% against a 6.19% average reaction, with dealers long gamma and max pain at $12.
Live updates
Nov 5 — ATM implied vol 95.5% to 133.6%. The straddle now prices ±18.81% with ABCL at $12.28 and dealers long gamma.
AbCellera Biologics Inc. reports on November 5, 2026. The November 20, 2026 straddle is priced at $2.31, an implied move of ±18.81% against an average realised reaction of 6.19% over the last 7 prints. The stock trades at $12.28, -18.2% from its 52-week high, with dealers long gamma and max pain at $12.
What the options market is pricing
| Measure | Level |
|---|---|
| November 5, 2026 | |
| Expiry used | November 20, 2026 (15 days out) |
| Spot | $12.28 |
| ATM straddle | $2.31 |
| Implied move | ±18.81% ($9.97 to $14.59) |
| ATM implied vol | 133.6% |
| Put/call open interest | 0.47 |
| Max pain | $12 |
| Net dealer gamma | +$0.12mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $16 (3,243 contracts) |
| Heaviest put strike below spot | $11 (3,613 contracts) |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ABCL between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Aug 5 | +10.30% |
| Q1 2026, May 11 | -5.71% |
| Q4 2025, Feb 24 | -0.93% |
| Q3 2025, Nov 6 | -13.69% |
| Q2 2025, Aug 7 | +0.24% |
| Q1 2025, May 8 | +1.00% |
| Q4 2024, Feb 27 | -11.47% |
Across the last 7 prints the average absolute reaction is 6.19%, with 3 higher and 4 lower. The best was +10.30% and the worst -13.69%. Options are asking ±18.81%, which is 12.62 points richer than the realised average, the premium seller's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $12.28 |
| 52-week range | $2.75 to $15.02 |
| Position in that range | 78% |
| From the 52-week high | -18.2% |
| From the 52-week low | +347.4% |
| Past week | -10.0% |
| Past month | -6.6% |
| Past three months | +88.1% |
| 50-day average | $12.31 |
| 200-day average | $6.97 |
How the options market is pricing it
The November 20, 2026 straddle marks $9.97 to $14.59 as the range the options market is paying for into the print, with ATM implied vol at 134% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ABCL has moved 6.19% on earnings against the ±18.81% now implied, so the market is pricing this print richer than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ABCL before the print.
Data as of November 5, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ABCL options memo